105 related articles for article (PubMed ID: 2529430)
1. In vitro interrelations between axillary lymph nodes and breast carcinomas from patients immunostimulated before surgery.
Kiricuţă I; Papilian-Todoruţiu C; Rişcă R; Mulea R; Daicoviciu D
Morphol Embryol (Bucur); 1989; 35(2):129-37. PubMed ID: 2529430
[TBL] [Abstract][Full Text] [Related]
2. Axillary lymph-node and breast carcinoma interrelations in organ culture.
Kiricuta I; Todorutiu C; Mulea R; Risca R
Cancer; 1978 Dec; 42(6):2710-5. PubMed ID: 728869
[TBL] [Abstract][Full Text] [Related]
3. Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures.
Pigott J; Nichols R; Maddox WA; Balch CM
Surg Gynecol Obstet; 1984 Mar; 158(3):255-9. PubMed ID: 6701738
[TBL] [Abstract][Full Text] [Related]
4. Survival with mammary cancer related to the interaction of germinal center hyperplasia and sinus histiocytosis in axillary and internal mammary lymph nodes.
Hunter RL; Ferguson DJ; Coppleson LW
Cancer; 1975 Aug; 36(2):528-39. PubMed ID: 168957
[TBL] [Abstract][Full Text] [Related]
5. Human regional tumour lymph nodes: alterations of micro-architecture and lymphocyte subpopulations.
Eremin O; Roberts P; Plumb D; Stephens JP
Br J Cancer; 1980 Jan; 41(1):62-72. PubMed ID: 7362780
[TBL] [Abstract][Full Text] [Related]
6. The relationship between cytotoxicity and prognostically significant histologic changes in lymph nodes from patients with cancer of the breast.
Check IJ; Cobb M; Hunter RL
Am J Pathol; 1980 Feb; 98(2):325-38. PubMed ID: 6243870
[TBL] [Abstract][Full Text] [Related]
7. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast.
Fisher B; Wolmark N; Bauer M; Redmond C; Gebhardt M
Surg Gynecol Obstet; 1981 Jun; 152(6):765-72. PubMed ID: 7244951
[No Abstract] [Full Text] [Related]
8. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
[TBL] [Abstract][Full Text] [Related]
9. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
11. [Preoperative staging of axillary lymph nodes in breast cancer: ultrasonographic parameters and ultrasound-guided core needle biopsy].
Torres Sousa MY; Banegas Illescas ME; Rozas Rodríguez ML; Arias Ortega M; González López LM; Martín García JJ; Ruiz Ortega L
Radiologia; 2011; 53(6):544-51. PubMed ID: 21565373
[TBL] [Abstract][Full Text] [Related]
12. Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). II. The significance of regional node histology other than sinus histiocytosis in invasive mammary cancer.
Fisher ER; Gregorio R; Redmond C; Dekker A; Fisher B
Am J Clin Pathol; 1976 Jan; 65(1):21-30. PubMed ID: 174420
[TBL] [Abstract][Full Text] [Related]
13. [The correlation between evidence of breast-cancer in the nipple and the axillary lymph nodes in cancer of the breast in women (author's transl)].
Kochem HG; Schremmer CN; Norpoth N; Hirche H
Geburtshilfe Frauenheilkd; 1981 Feb; 41(2):141-4. PubMed ID: 6908865
[TBL] [Abstract][Full Text] [Related]
14. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study.
Dowlatshahi K; Fan M; Bloom KJ; Spitz DJ; Patel S; Snider HC
Cancer; 1999 Sep; 86(6):990-6. PubMed ID: 10491525
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
Crippa F; Agresti R; Seregni E; Greco M; Pascali C; Bogni A; Chiesa C; De Sanctis V; Delledonne V; Salvadori B; Leutner M; Bombardieri E
J Nucl Med; 1998 Jan; 39(1):4-8. PubMed ID: 9443729
[TBL] [Abstract][Full Text] [Related]
16. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.
Rouzier R; Extra JM; Klijanienko J; Falcou MC; Asselain B; Vincent-Salomon A; Vielh P; Bourstyn E
J Clin Oncol; 2002 Mar; 20(5):1304-10. PubMed ID: 11870173
[TBL] [Abstract][Full Text] [Related]
17. Host resistance in relation to survival in breast cancer.
Di Paola M; Angelini L; Bertolotti A; Colizza S
Br Med J; 1974 Nov; 4(5939):268-70. PubMed ID: 4425855
[TBL] [Abstract][Full Text] [Related]
18. [Cellular reactions in tumor stroma and reactive changes in regional lymph nodes in breast cancer].
Fedin IuV; Ermilova VD
Vopr Onkol; 1984; 30(11):38-44. PubMed ID: 6334934
[TBL] [Abstract][Full Text] [Related]
19. Quantitative morphologic assessment of immunoreactivity in regional lymph nodes of patients with carcinoma of the breast.
Wernicke M
Surg Gynecol Obstet; 1975 Jun; 140(6):919-24. PubMed ID: 1129683
[TBL] [Abstract][Full Text] [Related]
20. Nevus cells in axillary lymph nodes from radical mastectomy specimens.
Andreola S; Clemente C
Pathol Res Pract; 1985 May; 179(6):616-8. PubMed ID: 4022839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
